Cargando…

Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma

BACKGROUND: To determine safe surgical margins for soft tissue sarcoma, it is essential to perform a general evaluation of the extent of tumor, responses to auxiliary therapy, and other factors preoperatively using multiple types of diagnostic imaging. 18F-fluorodeoxyglucose positron emission tomogr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokouchi, Masahiro, Terahara, Mikio, Nagano, Satoshi, Arishima, Yoshiya, Zemmyo, Michihisa, Yoshioka, Takako, Tanimoto, Akihide, Komiya, Setsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224246/
https://www.ncbi.nlm.nih.gov/pubmed/21774838
http://dx.doi.org/10.1186/1471-2474-12-166
_version_ 1782217359849684992
author Yokouchi, Masahiro
Terahara, Mikio
Nagano, Satoshi
Arishima, Yoshiya
Zemmyo, Michihisa
Yoshioka, Takako
Tanimoto, Akihide
Komiya, Setsuro
author_facet Yokouchi, Masahiro
Terahara, Mikio
Nagano, Satoshi
Arishima, Yoshiya
Zemmyo, Michihisa
Yoshioka, Takako
Tanimoto, Akihide
Komiya, Setsuro
author_sort Yokouchi, Masahiro
collection PubMed
description BACKGROUND: To determine safe surgical margins for soft tissue sarcoma, it is essential to perform a general evaluation of the extent of tumor, responses to auxiliary therapy, and other factors preoperatively using multiple types of diagnostic imaging. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is a tool for diagnostic imaging that has recently spread rapidly in clinical use. At present, the roles played by FDG-PET/CT in determination of margins for surgical resection of sarcoma are unclear. The present study was undertaken to explore the roles of FDG-PET/CT in determination of surgical margins for soft tissue sarcoma and to examine whether PET can serve as a standard means for setting the margins of surgical resection during reduced surgery. METHODS: The study involved 7 patients with sarcoma who underwent surgery in our department and in whom evaluation with FDG-PET/CT was possible. Sarcoma was histologically rated as MFH in 6 cases and leiomyosarcoma in 1 case. In all cases, sarcoma was superficial (T1a or T2a). The tumor border was defined by contrast-enhanced MRI, and SUVs were measured at intervals of 1 cm over a 5-cm long area from the tumor border. Mapping of viable tumor cells was carried out on whole-mount sections of resected tissue, and SUVs were compared with histopathological findings. RESULTS: Preoperative maximum SUVs (SUV-max) of the tumor averaged 11.7 (range: 3.8-22.1). Mean SUV-max was 2.2 (range: 0.3-3.8) at 1 cm from the tumor border, 1.1 (0.85-1.47) at 2 cm, 0.83 (0.65-1.15) at 3 cm, 0.7 (0.42-0.95) at 4 cm, and 0.64 (0.45-0.82) at 5 cm. When resected tissue was mapped, tumor cells were absent in the areas where SUV-max was below 1.0. CONCLUSIONS: Our findings suggest that a safe surgical margin free of viable tumor cells can be ensured if the SUV cut-off level is set at 1.0. FDG-PET/CT is promising as a diagnostic imaging technique for setting of safe minimal margins for surgical resection of soft tissue sarcoma.
format Online
Article
Text
id pubmed-3224246
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32242462011-11-27 Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma Yokouchi, Masahiro Terahara, Mikio Nagano, Satoshi Arishima, Yoshiya Zemmyo, Michihisa Yoshioka, Takako Tanimoto, Akihide Komiya, Setsuro BMC Musculoskelet Disord Research Article BACKGROUND: To determine safe surgical margins for soft tissue sarcoma, it is essential to perform a general evaluation of the extent of tumor, responses to auxiliary therapy, and other factors preoperatively using multiple types of diagnostic imaging. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is a tool for diagnostic imaging that has recently spread rapidly in clinical use. At present, the roles played by FDG-PET/CT in determination of margins for surgical resection of sarcoma are unclear. The present study was undertaken to explore the roles of FDG-PET/CT in determination of surgical margins for soft tissue sarcoma and to examine whether PET can serve as a standard means for setting the margins of surgical resection during reduced surgery. METHODS: The study involved 7 patients with sarcoma who underwent surgery in our department and in whom evaluation with FDG-PET/CT was possible. Sarcoma was histologically rated as MFH in 6 cases and leiomyosarcoma in 1 case. In all cases, sarcoma was superficial (T1a or T2a). The tumor border was defined by contrast-enhanced MRI, and SUVs were measured at intervals of 1 cm over a 5-cm long area from the tumor border. Mapping of viable tumor cells was carried out on whole-mount sections of resected tissue, and SUVs were compared with histopathological findings. RESULTS: Preoperative maximum SUVs (SUV-max) of the tumor averaged 11.7 (range: 3.8-22.1). Mean SUV-max was 2.2 (range: 0.3-3.8) at 1 cm from the tumor border, 1.1 (0.85-1.47) at 2 cm, 0.83 (0.65-1.15) at 3 cm, 0.7 (0.42-0.95) at 4 cm, and 0.64 (0.45-0.82) at 5 cm. When resected tissue was mapped, tumor cells were absent in the areas where SUV-max was below 1.0. CONCLUSIONS: Our findings suggest that a safe surgical margin free of viable tumor cells can be ensured if the SUV cut-off level is set at 1.0. FDG-PET/CT is promising as a diagnostic imaging technique for setting of safe minimal margins for surgical resection of soft tissue sarcoma. BioMed Central 2011-07-21 /pmc/articles/PMC3224246/ /pubmed/21774838 http://dx.doi.org/10.1186/1471-2474-12-166 Text en Copyright ©2011 Yokouchi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yokouchi, Masahiro
Terahara, Mikio
Nagano, Satoshi
Arishima, Yoshiya
Zemmyo, Michihisa
Yoshioka, Takako
Tanimoto, Akihide
Komiya, Setsuro
Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma
title Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma
title_full Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma
title_fullStr Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma
title_full_unstemmed Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma
title_short Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma
title_sort clinical implications of determination of safe surgical margins by using a combination of ct and 18fdg-positron emission tomography in soft tissue sarcoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224246/
https://www.ncbi.nlm.nih.gov/pubmed/21774838
http://dx.doi.org/10.1186/1471-2474-12-166
work_keys_str_mv AT yokouchimasahiro clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma
AT teraharamikio clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma
AT naganosatoshi clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma
AT arishimayoshiya clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma
AT zemmyomichihisa clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma
AT yoshiokatakako clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma
AT tanimotoakihide clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma
AT komiyasetsuro clinicalimplicationsofdeterminationofsafesurgicalmarginsbyusingacombinationofctand18fdgpositronemissiontomographyinsofttissuesarcoma